4-Amino-2,3-difluoro-5-nitrobenzoic Acid - CAS 284030-57-5
Catalog: |
BB019841 |
Product Name: |
4-Amino-2,3-difluoro-5-nitrobenzoic Acid |
CAS: |
284030-57-5 |
Synonyms: |
4-amino-2,3-difluoro-5-nitrobenzoic acid; 4-amino-2,3-difluoro-5-nitrobenzoic acid |
IUPAC Name: | 4-amino-2,3-difluoro-5-nitrobenzoic acid |
Description: | 4-Amino-2,3-difluoro-5-nitrobenzoic Acid (CAS# 284030-57-5) is a useful research chemical. |
Molecular Weight: | 218.11 |
Molecular Formula: | C7H4F2N2O4 |
Canonical SMILES: | C1=C(C(=C(C(=C1[N+](=O)[O-])N)F)F)C(=O)O |
InChI: | InChI=1S/C7H4F2N2O4/c8-4-2(7(12)13)1-3(11(14)15)6(10)5(4)9/h1H,10H2,(H,12,13) |
InChI Key: | WXXHOWQPFHXRDY-UHFFFAOYSA-N |
Boiling Point: | 401.139 °C at 760 mmHg |
Density: | 1.751 g/cm3 |
MDL: | MFCD08543937 |
LogP: | 2.25780 |
Publication Number | Title | Priority Date |
WO-2020212832-A1 | Process of preparation of benzimidazole compounds | 20190416 |
AU-2013235596-A1 | Combination therapy of a MEK inhibitor and IGF1R inhibitor | 20120320 |
AU-2013235596-B2 | Combination therapy of a MEK inhibitor and IGF1R inhibitor | 20120320 |
AU-2013235596-B9 | Combination therapy of a MEK inhibitor and IGF1R inhibitor | 20120320 |
CA-2868000-A1 | Pharmaceutical combination comprising a mek inhibitor compound and an a nti-igfir antibody for treating cancer | 20120320 |
Complexity: | 283 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 218.01391294 |
Formal Charge: | 0 |
Heavy Atom Count: | 15 |
Hydrogen Bond Acceptor Count: | 7 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 218.01391294 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 109 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS